Key points are not available for this paper at this time.
A 60-year-old man with fatigue and a perinephric mass was found to have Rosai–Dorfman disease expressing an activating mutation in KRAS. A course of therapy with oral cobimetinib produced a respons...
Jacobsen et al. (Wed,) studied this question.